SOHM, INC. ANNOUNCES ITS 3RD QTR. 2018 RESULTS AND UPDATES
CHINO HILLS, NOVEMBER 26, 2018 – SOHM, Inc. (Pink Sheets: SHMN), is a generic Pharmaceutical, Nutraceutical and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories.
Management is very pleased to announce 3rd quarter revenues of $397,688 as of September 30, 2018. Revenue growth for the first nine months of 2018 increased by 228% as compared to the annual gross revenue of $173,955 for the year 2017. A gross profit of $183,134 was realized in just the first nine months of 2018. An increase of 177% when compared to the $103,366 twelve-month gross profit for the year 2017.
Management’s operational and development goals are on track.
Mr. Baron Night, company CEO, added that Company growth was made possible by his predecessor’s continuing focus on adhering to Management’s operational and development goals during the year 2017 and 2018.
Mr. Night states that the company has not issued any stock to anyone including promoters, officers, directors, and/or employees in the last several years. The purpose of the stock issued in April 2018 was to retire financial notes as explained by corporate counsel. Company management has no immediate plans to engage in any major restructuring of its share structure. Every company has revenue growth challenges. We are working towards reducing costs, stabilizing revenue markets, and improving growth.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro.”. SOHM manufacturing and marketing targets the rapidly growing healthcare areas of Nutraceuticals, Cosmeceuticals, and other major therapeutic markets. SOHM is headquartered in North America with manufacturing in India and continuing strategic alliances with US manufacturing firms. SOHM’s generic pharmaceuticals are exported globally and were introduced to the US market in early 2013. SOHM continues to expand product distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700